Top argenx Alternatives

Global immunology company developing antibody-based therapies for severe autoimmune diseases.

A

argenx

Global immunology company developing antibody-based therapies for severe autoimmune diseases.

$51.1M raised
Amsterdam, Netherlands
BiTech
Biopharmaceuticals
Immunology

20 Similar Companies in BiTech

Ranked by total score and funding data on StartupHub.ai

Immunai
Immunai

Immunai

Healthcare
Immunology
$295.0M
195 employees
Recursion Pharmaceuticals
Recursion Pharmaceuticals

Recursion Pharmaceuticals

Uses AI and automation to industrialize drug discovery and development for rare diseases and cancers.

Drug Discovery AI
Biotech
$623.0M
Salt Lake City, United States
Janux Therapeutics
Janux Therapeutics

Janux Therapeutics

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotechnology
Pharmaceuticals
$181.0M
San Diego, California, USA
110 employees
DeepCure
DeepCure

DeepCure

Healthcare
Drug Discovery
$65.4M
31 employees
Ukko
Ukko

Ukko

Healthcare
Allergen
$40.0M
55 employees
Alector
Alector

Alector

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotech
MedTech
$162.5M
South San Francisco, United States
151 employees
Nectin Therapeutics
Nectin Therapeutics

Nectin Therapeutics

Life Sciences
Immunotherapy
$25.0M
11 employees
Dren Bio
Dren Bio

Dren Bio

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Biotech
Drug Discovery
$156.0M
San Carlos, United States
K

Kamada Pharmaceuticals

Global biopharmaceutical company specializing in plasma-derived therapeutics for rare and serious conditions.

Biopharma
Plasma-derived therapeutics
$150.0M
Rehovot, Israel
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Biotechnology
Biopharmaceuticals
$435.9M
Watertown, United States
Compugen
Compugen

Compugen

Oncology
Immunology
$102.0M
E

Excalipoint Therapeutics

Developing next-generation T-cell engager therapies for cancer and autoimmune diseases.

Biotechnology
Pharmaceuticals
$68.7M
Shanghai, China
Biolojic Design
Biolojic Design

Biolojic Design

Healthcare
Drug Discovery
94 employees
ImmunoBrain Checkpoint
ImmunoBrain Checkpoint

ImmunoBrain Checkpoint

Healthcare
Immunology
14 employees
Gilboa Therapeutics
Gilboa Therapeutics

Gilboa Therapeutics

Biopharmaceuticals
Immunotherapy
6 employees
NanoGhost
NanoGhost

NanoGhost

Life Sciences
Drug Delivery
12 employees
EdiTy Therapeutics
EdiTy Therapeutics

EdiTy Therapeutics

Life Sciences
Immunology
16 employees
C

CDR3

Healthcare
Immunology
I

Immunarray

Healthcare
Blood
$10.0M

About argenx and Alternatives

argenx is a BiTech company global immunology company developing antibody-based therapies for severe autoimmune diseases.. If you're evaluating BiTech solutions, these 20 alternatives offer similar capabilities and market positioning. StartupHub.ai tracks funding, team composition, and competitive positioning across 11,000+ AI startups to help you make informed decisions. Browse each profile to compare founders, investors, and funding history.